NOBILIS MAREK THV LYO

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

HERPES VIRUS STRAIN PB-THV 1 LIVE TURKEY

Available from:

Intervet Ireland Limited

ATC code:

QI01AD

Pharmaceutical form:

Pdr+Solv for Soln for Inj

Therapeutic group:

Immunological - Live Vaccine

Therapeutic area:

Fowl - Chicken

Authorization date:

2003-12-17

Summary of Product characteristics

PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Nobilis Marek THV lyo
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Active ingredients:
VACCINE
Per dose
Turkey herpesvirus strain PB-THV-1 
Minimum: 1000 pfu*
The vaccine contains gentamycin as a remnant of production.
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Powder and solvent for solution for injection
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Chickens, from one day to three weeks of age.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For active immunisation of chickens to reduce clinical signs and/or lesions of virulent Marek’s Disease. Protection is
seen by 8 days after vaccination.
4.3 CONTRAINDICATIONS
Do not use in unhealthy birds. Sick or weak birds may not develop adequate immunity following vaccination.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 16/01/2007_
_CRN 7002913_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
The vaccine virus may spread to susceptible, unvaccinated birds.
A good immune response is reliant on the reaction of an immunogenic agent and a fully competent immune system.
Immunogenicity of the vaccine antigen will be reduced by poor storage or inappropriate administration.
Immuno-competence of the animal may be compromised by a variety of factors including poor health, nutritional
status, genetic factors, concurrent drug therapy and stress.
Under certain conditions, for example extreme disease pressure, fully immune birds may succumb to disease.
Therefore, successful vaccination may not be synonymous with full protection in the face of a disease challenge.